位置:首页 > 蛋白库 > SG1_RAUSE
SG1_RAUSE
ID   SG1_RAUSE               Reviewed;         532 AA.
AC   Q8GU20;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   03-AUG-2022, entry version 77.
DE   RecName: Full=Strictosidine-O-beta-D-glucosidase;
DE            EC=3.2.1.105;
GN   Name=SGR1;
OS   Rauvolfia serpentina (Serpentine wood) (Ophioxylon serpentinum).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; lamiids; Gentianales; Apocynaceae; Rauvolfioideae; Vinceae;
OC   Rauvolfiinae; Rauvolfia.
OX   NCBI_TaxID=4060;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Protoplast;
RA   Gerasimenko I., Sheludko Y., Stoeckigt J.;
RT   "Molecular cloning and functional bacterial expression of strictosidine
RT   glucosidase from Rauvolfia serpentina cell suspension cultures.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22004291; DOI=10.1021/cb200267w;
RA   Xia L., Ruppert M., Wang M., Panjikar S., Lin H., Rajendran C.,
RA   Barleben L., Stoeckigt J.;
RT   "Structures of alkaloid biosynthetic glucosidases decode substrate
RT   specificity.";
RL   ACS Chem. Biol. 7:226-234(2012).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS) IN COMPLEX WITH SUBSTRATE,
RP   MUTAGENESIS OF HIS-161; GLU-207; PHE-373; GLY-386; TRP-388; GLU-416 AND
RP   TYR-481, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17890378; DOI=10.1105/tpc.106.045682;
RA   Barleben L., Panjikar S., Ruppert M., Koepke J., Stoeckigt J.;
RT   "Molecular architecture of strictosidine glucosidase: the gateway to the
RT   biosynthesis of the monoterpenoid indole alkaloid family.";
RL   Plant Cell 19:2886-2897(2007).
CC   -!- FUNCTION: Glucosidase specifically involved in alkaloid biosynthesis
CC       leading to the accumulation of several alkaloids, including ajmaline,
CC       an important plant-derived pharmaceutical used in the therapy of heart
CC       disorders. {ECO:0000269|PubMed:22004291}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3alpha(S)-strictosidine + H2O = D-glucose + strictosidine
CC         aglycone; Xref=Rhea:RHEA:12917, ChEBI:CHEBI:4167, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:58012, ChEBI:CHEBI:58193; EC=3.2.1.105;
CC         Evidence={ECO:0000269|PubMed:17890378};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=90 uM for strictosidine (at pH 5.7 and 30 degrees Celsius)
CC         {ECO:0000269|PubMed:17890378};
CC         KM=120 uM for strictosidine {ECO:0000269|PubMed:22004291};
CC         Note=kcat is 9.8 sec(-1) with strictosidine as substrate (at pH 5.7
CC         and 30 degrees Celsius. {ECO:0000269|PubMed:17890378};
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ302044; CAC83098.1; -; mRNA.
DR   PDB; 2JF6; X-ray; 2.82 A; A/B=1-532.
DR   PDB; 2JF7; X-ray; 2.48 A; A/B=1-532.
DR   PDB; 3ZJ7; X-ray; 2.50 A; A/B=1-532.
DR   PDB; 3ZJ8; X-ray; 3.01 A; A/B=1-532.
DR   PDBsum; 2JF6; -.
DR   PDBsum; 2JF7; -.
DR   PDBsum; 3ZJ7; -.
DR   PDBsum; 3ZJ8; -.
DR   AlphaFoldDB; Q8GU20; -.
DR   SMR; Q8GU20; -.
DR   CAZy; GH1; Glycoside Hydrolase Family 1.
DR   PRIDE; Q8GU20; -.
DR   KEGG; ag:CAC83098; -.
DR   BioCyc; MetaCyc:MON-12391; -.
DR   BRENDA; 3.2.1.105; 5309.
DR   EvolutionaryTrace; Q8GU20; -.
DR   GO; GO:0050422; F:strictosidine beta-glucosidase activity; IDA:UniProtKB.
DR   GO; GO:0009821; P:alkaloid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   InterPro; IPR001360; Glyco_hydro_1.
DR   InterPro; IPR033132; Glyco_hydro_1_N_CS.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR10353; PTHR10353; 1.
DR   Pfam; PF00232; Glyco_hydro_1; 1.
DR   PRINTS; PR00131; GLHYDRLASE1.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   PROSITE; PS00653; GLYCOSYL_HYDROL_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alkaloid metabolism; Glycosidase; Hydrolase.
FT   CHAIN           1..532
FT                   /note="Strictosidine-O-beta-D-glucosidase"
FT                   /id="PRO_0000418401"
FT   REGION          512..532
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        513..532
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        207
FT                   /note="Proton donor"
FT   ACT_SITE        416
FT                   /note="Nucleophile"
FT   BINDING         57
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   BINDING         161
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   BINDING         206..207
FT                   /ligand="substrate"
FT   BINDING         345
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         388
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   BINDING         465
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   BINDING         472..473
FT                   /ligand="substrate"
FT   BINDING         481
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   SITE            388
FT                   /note="Controls the gate shape and acceptance of
FT                   substrates"
FT   MUTAGEN         161
FT                   /note="H->L,N: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   MUTAGEN         207
FT                   /note="E->D,Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   MUTAGEN         373
FT                   /note="F->T: Reduced affinity but increased activity."
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   MUTAGEN         386
FT                   /note="G->S: Reduced affinity and activity."
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   MUTAGEN         388
FT                   /note="W->A: Loss of activity and reduced affinity."
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   MUTAGEN         416
FT                   /note="E->D,Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   MUTAGEN         481
FT                   /note="Y->F: Reduced affinity."
FT                   /evidence="ECO:0000269|PubMed:17890378"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          48..52
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           55..58
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           71..78
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           80..82
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          89..91
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           95..109
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          112..117
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           120..123
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           135..150
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          154..162
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           166..172
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           174..176
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           180..195
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           196..198
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          200..206
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           208..216
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:3ZJ7"
FT   TURN            234..236
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           237..259
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           261..264
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          267..273
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          276..283
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           284..297
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           299..302
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           304..307
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           312..318
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           327..333
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          340..343
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          347..352
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           363..366
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          369..377
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          379..383
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           393..407
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          412..417
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          425..427
FT                   /evidence="ECO:0007829|PDB:2JF6"
FT   HELIX           429..432
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           436..454
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          459..465
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           473..475
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          478..480
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          483..486
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   TURN            488..490
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   STRAND          493..495
FT                   /evidence="ECO:0007829|PDB:2JF7"
FT   HELIX           497..507
FT                   /evidence="ECO:0007829|PDB:2JF7"
SQ   SEQUENCE   532 AA;  60881 MW;  FC65D93E90212710 CRC64;
     MDNTQAEPLV VAIVPKPNAS TEHTNSHLIP VTRSKIVVHR RDFPQDFIFG AGGSAYQCEG
     AYNEGNRGPS IWDTFTQRSP AKISDGSNGN QAINCYHMYK EDIKIMKQTG LESYRFSISW
     SRVLPGGRLA AGVNKDGVKF YHDFIDELLA NGIKPSVTLF HWDLPQALED EYGGFLSHRI
     VDDFCEYAEF CFWEFGDKIK YWTTFNEPHT FAVNGYALGE FAPGRGGKGD EGDPAIEPYV
     VTHNILLAHK AAVEEYRNKF QKCQEGEIGI VLNSMWMEPL SDVQADIDAQ KRALDFMLGW
     FLEPLTTGDY PKSMRELVKG RLPKFSADDS EKLKGCYDFI GMNYYTATYV TNAVKSNSEK
     LSYETDDQVT KTFERNQKPI GHALYGGWQH VVPWGLYKLL VYTKETYHVP VLYVTESGMV
     EENKTKILLS EARRDAERTD YHQKHLASVR DAIDDGVNVK GYFVWSFFDN FEWNLGYICR
     YGIIHVDYKS FERYPKESAI WYKNFIAGKS TTSPAKRRRE EAQVELVKRQ KT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024